Cargando…
Five-year clinical outcomes following drug-eluting stent implantation in left main trifurcations
Autores principales: | Gil, Robert J., Bil, Jacek, Kern, Adam K., Garcia, Luis A. Inigo, Formuszewicz, Radoslaw, Dobrzycki, Slawomir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488829/ https://www.ncbi.nlm.nih.gov/pubmed/31043994 http://dx.doi.org/10.5114/aic.2019.83777 |
Ejemplares similares
-
Mehran in-stent restenosis classification adapted for coronary bifurcations: the impact on 4-year follow-up from randomized clinical studies POLBOS I and II
por: Bil, Jacek, et al.
Publicado: (2018) -
Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies
por: Gil, Robert J., et al.
Publicado: (2020) -
Successful Culotte Stenting for Unprotected Left Main Trifurcation Disease: Insights from Optical Coherence Tomography
por: Kim, Yongcheol, et al.
Publicado: (2020) -
A new sequential two-stent strategy for treating true distal left main trifurcation lesion
por: DAI, Yu-Xiang, et al.
Publicado: (2021) -
Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stent
por: Gil, Robert J., et al.
Publicado: (2019)